Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 14:47:13 +0200Tue, 14 May 2024 14:10:00 +0200Poteligeo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4232_en_2.pdfPoteligeo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4232_en_2.pdfTue, 14 May 2024 14:10:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/poteligeoHuman medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/poteligeoTue, 14 May 2024 13:15:00 +0200Human medicine